The Can.Heal project aims at aligning clinical and population-based interventions. By exploiting the increasing wealth of data on genomes it will allow better and earlier diagnosis. And by taking account of regulatory, scientific, economic, research and gender perspectives, it will increasingly make it possible to give the right treatment to the right patient at the right time. This is not only better for patients: it can also bring benefits to health care systems. Improved diagnoses and more effectively targeted treatments can help to reduce lost time for patients and doctors, and avoid waste of resources. The two strands of the project – care and protection – are reflected in the title CAN.HEAL.

The CAN.HEAL consortium recognises that prevention, diagnosis and treatment should be approached in a concerted way for optimal benefit of patients and citizens. They focus on applying ‘next generation sequencing’ technology and identifying implementation paths to extend the application of genetic profiling to structure omics use in patient care, share data among EU Cancer Centres which would improve equity in treatment, and allow better counselling regarding cancer risk using molecular tumour profiling biomarkers. They wish to set the framework for integrating the Genome of Europe biobanking initiative into public health genomics for cancer.


1. Drive a process to allow framework to implement NGS and PHG into healthcare systems to ensure early diagnosis

2. Provide operational feedback from stakeholders to the other WPs

3. Ensure effective external communication and dissemination of key findings

Web page



Reducing disparities across the European Union

Despite significant advances in cancer therapy, there is still a long road ahead to improve disparities in cancer screening, diagnosis, treatment, quality of life, management of survivorship, and palliative care at the end of life. Among the challenges encountered within and across Europe, the most common disparities are observed in accessing information, spiraling costs of healthcare, accessing optimal treatment options with complete treatment modalities and optimal outcomes, ensuring the best Quality of Life for patients during and after the treatment process, integrating cancer research and innovative cancer care, and accessing networked, multidisciplinary cancer care teams.

In response to this concerning scenario, the Cancer Care Beacon project focuses on three iterative pillars:

1. mapping of capacity and capabilities across cancer centers in the European Union;

2. creating decision support tools that will assist our four stakeholders: patients in finding the best centers, providers in sharing resources and expertise, researchers in sharing data, and policymakers in aligning funding allocation with patients' priorities;

3. getting training and accreditation to reflect the quality of their cancer care.


Throughout this project, they will deliver three main end products:

1. proposed roadmap to scale current capacity and capabilities in order to address existing cancer disparities,

2. a plethora of reports, including both static documents and interactive Web applications, aimed at supporting decision making by our four stakeholders,

3. a sustainability plan on how we intend to directly work with our partners to keep the project alive and active beyond the two-year duration of the funding by EU4Health.


The Cancer Care Beacon project focuses on three iterative pillars:

1. Data collection

2. Strategy and Direction

3. Treatment

Web page